Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Oncophage vs Observation in High-Risk Renal Cell Carcinoma
2004-004572-36Phase 3Completed
- Sponsor
- Agenus Inc.
- Start
- Jul 2005
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in renal cell carcinoma (RCC) comparing Adjuvant Oncophage with Observation (2 arms). Primary endpoint: Recurrence-free survival. Started Jul 2005; status: completed.
02
Drugs
vitespen
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on 2004-004572-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004572-36.